Cargando…
Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood–brain barrier and glioma cells
Clinical applications of siRNA for treating disorders in the central nervous system require development of systemic stable, safe, and effective delivery vehicles that are able to cross the impermeable blood–brain barrier (BBB). Engineering nanocarriers with low cellular interaction during systemic c...
Autores principales: | Bruun, Jonas, Larsen, Trine B, Jølck, Rasmus I, Eliasen, Rasmus, Holm, René, Gjetting, Torben, Andresen, Thomas L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590347/ https://www.ncbi.nlm.nih.gov/pubmed/26451106 http://dx.doi.org/10.2147/IJN.S87334 |
Ejemplares similares
-
Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013) -
Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014) -
Knocking down barriers: advances in siRNA delivery
por: Whitehead, Kathryn A., et al.
Publicado: (2009) -
Side Chain Hydrophobicity Modulates Therapeutic Activity and Membrane Selectivity of Antimicrobial Peptide Mastoparan-X
por: Henriksen, Jonas R., et al.
Publicado: (2014) -
Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
por: Liu, Hong-Mei, et al.
Publicado: (2017)